Niobay Metals Inc. (NBYCF)

[roberttatge]

CEO SELLS PART OF HIS HOLDINGS

Niobay Metals Inc (NBY) Director Sells C$16,170.00 in Stock

Posted by Donnie Miller on Jan 20th, 2017 // No Comments
in Share.
Niobay Metals logoNiobay Metals Inc (TSE:NBY) Director Claude Dufresne sold 21,000 shares of the company’s stock in a transaction that occurred on Thursday, January 12th. The shares were sold at an average price of C$0.77, for a total value of C$16,170.00.

Niobay Metals Company Profile

NovaBay Pharmaceuticals, Inc, formerly NovaCal Pharmaceuticals, Inc, is a biopharmaceutical company, which develops products for the eye care market. The Company focuses on commercializing prescription Avenova for managing hygiene of the eyelids and lashes in the United States. Avenova is an eye care product formulated with a form of hypochlorous acid called Neutrox.